Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum.
Small interfering (si)RNAs have recently been used to therapeutically silence genes in vivo after intravenous systemic delivery. Further progress in the development of siRNA therapeutics will in part rely on tailoring site-specific chemical modifications of siRNAs to optimize their pharmacokinetic properties. Advances are particularly needed to improve the nucleolytic stability of these double-stranded RNA drugs in vivo and suppress adverse off-target gene silencing effects. Here we demonstrate that specific chemical 2'-O-methylation, which has already been shown to ameliorate the omnipresent off-target toxicity of siRNAs, selectively protects the particularly vulnerable 5'-end of the guide strand against exonucleolytic degradation in human blood serum. Specific chemical modification thus resolves the asymmetric degradation of the guide and passenger strands, which is inherent to the thermodynamic asymmetry of the siRNA termini as required for proper utilization of the guide strand in RNA interference.
Hoerter
John A H
JA
Department of Chemistry, University of Michigan, Ann Arbor, MI 48109-1055, USA.
Walter
Nils G
NG
D020029:Base Pairing; D001483:Base Sequence; D006801:Humans; D008745:Methylation; D008969:Molecular Sequence Data; D020871:RNA Stability; D012330:RNA, Double-Stranded / Q000737:chemistry / Q000378:metabolism; D034741:RNA, Small Interfering / Q000097:blood* / Q000737:chemistry* / Q000378:metabolism; D013816:Thermodynamics